Comerica Bank’s Sage Therapeutics SAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.09K | Hold |
120
| – | – | ﹤0.01% | 3573 |
|
|
2025
Q1 | $954 | Hold |
120
| – | – | ﹤0.01% | 3568 |
|
|
2024
Q4 | $652 | Buy |
120
+112
| +1,400% | +$609 | ﹤0.01% | 3594 |
|
|
2024
Q3 | $58 | Sell |
8
-23
| -74% | -$167 | ﹤0.01% | 3656 |
|
|
2024
Q2 | $337 | Sell |
31
-295
| -90% | -$3.21K | ﹤0.01% | 3640 |
|
|
2024
Q1 | $6.11K | Sell |
326
-10
| -3% | -$187 | ﹤0.01% | 3294 |
|
|
2023
Q4 | $7.28K | Buy |
336
+269
| +401% | +$5.83K | ﹤0.01% | 3231 |
|
|
2023
Q3 | $1.38K | Buy |
+67
| New | +$1.38K | ﹤0.01% | 3632 |
|
|
2021
Q1 | – | Sell |
-29,469
| Closed | -$2.61M | – | 2358 |
|
|
2020
Q4 | $2.61M | Buy |
29,469
+8,129
| +38% | +$720K | 0.02% | 1139 |
|
|
2020
Q3 | $1.53M | Buy |
21,340
+5,072
| +31% | +$363K | 0.01% | 1311 |
|
|
2020
Q2 | $770K | Buy |
16,268
+1,545
| +10% | +$73.1K | 0.01% | 1666 |
|
|
2020
Q1 | $561K | Buy |
14,723
+4,763
| +48% | +$181K | 0.01% | 1673 |
|
|
2019
Q4 | $666K | Buy |
9,960
+2,380
| +31% | +$159K | 0.01% | 1765 |
|
|
2019
Q3 | $1.08M | Buy |
7,580
+5,695
| +302% | +$808K | 0.01% | 1486 |
|
|
2019
Q2 | $342K | Buy |
1,885
+259
| +16% | +$47K | ﹤0.01% | 2024 |
|
|
2019
Q1 | $278K | Buy |
+1,626
| New | +$278K | ﹤0.01% | 2091 |
|
|
2018
Q4 | – | Sell |
-1,632
| Closed | -$200K | – | 2294 |
|
|
2018
Q3 | $200K | Sell |
1,632
-35
| -2% | -$4.29K | ﹤0.01% | 2183 |
|
|
2018
Q2 | $282K | Buy |
1,667
+211
| +14% | +$35.7K | ﹤0.01% | 2091 |
|
|
2018
Q1 | $247K | Buy |
1,456
+113
| +8% | +$19.2K | ﹤0.01% | 2128 |
|
|
2017
Q4 | $242K | Buy |
+1,343
| New | +$242K | ﹤0.01% | 2145 |
|